WINGTECH(SH:600745) 证券时报·2025-10-23 13:35Core Viewpoint - The recent developments regarding Nexperia's management and operations in China highlight significant tensions between the Dutch government and the Chinese subsidiary, impacting business continuity and investor confidence [1][5]. Group 1: Company Statements - Nexperia China issued a formal statement asserting that the decision made by its Dutch headquarters to remove Zhang Qiuming from his position lacks legal validity in China [1]. - The company confirmed that Zhang Qiuming's role remains unchanged and that his actions continue to represent Nexperia China [1]. - Nexperia China emphasized that all business operations are proceeding normally and are not affected by external decisions, ensuring stability and continuity [1]. Group 2: Customer Communication - Nexperia China released a bilingual letter to customers, refuting claims made by the Dutch management regarding product compliance and quality standards, which they deemed misleading [3]. - The company assured that all products manufactured and delivered in China comply with local laws and regulations, meeting established technical standards and quality requirements [3]. - Nexperia China committed to communicating any changes in product supply or production processes to customers in advance [3]. Group 3: Regulatory and Legal Context - On October 12, it was reported that Nexperia faced restrictions from the Dutch government, including a one-year freeze on its assets and operations, affecting its global entities [5]. - The Dutch court intervened to suspend the chairman of the parent company, appointing an independent director with decisive voting rights, which further complicates governance [5]. - Chinese officials expressed concerns over the impact of these measures on global supply chain stability and urged the Dutch government to resolve the situation to protect Chinese investors' rights [5].